CHINA PHARMACEUTICAL MANUFACTURING
CASE STUDY -
Pharmaceutical Manufacturer Learns about Competitor in China
Client Request
-
Benchmark
a major competitor before operations move into China
-
Determine sales destination(s) of products produced in China
-
Find origin of Active Pharmaceutical Ingredients (API) and excipients
-
Learn future plans in China for competitor
Primary Impact Findings
- Pharmaceutics
and over-the-counter drugs manufactured for the Chinese domestic and
European markets
- Contract manufacturing
done for over-the-counter drugs being sold in China
- For each drug,
the supply of raw materials came from Europe until production operated
for a few months
- Excipients and
basic chemicals transitioned to Chinese suppliers trained by six sigma
process leader in lean manufacturing
- Active Pharmaceutical
Ingredients only sourced from Europe
- Capital investment
plan to triple revenues in five years
Primary Impact Recommendation
- Work
closely with the provincial drug agency and establish an anti-counterfeit
department to conduct regular fraud investigations
- Since the Chinese
government awards pharmaceutical contracts, detail the value of highly
skilled job creation and supplier training to be provided
Advantage - Our Clients
|
